Laurion Capital Management »

Madrigal Pharmaceuticals shares owned by Laurion Capital Management

Quarter-by-quarter ownership of Madrigal Pharmaceuticals (MDGL) shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in Madrigal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Madrigal Pharmaceuticals held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Madrigal Pharmaceuticals by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $2.3M 16k 146.04
2023-03-31 $225k 928 242.26
2019-12-31 $12M 136k 91.11
2019-09-30 $359k 4.2k 86.15

More positions owned by Laurion Capital Management

Ishares Tr Iboxx Hi Yd Etf (HYG)
Meta Platforms Cl A Call Option (META)
Apple (AAPL)
Tesla Motors Call Option (TSLA)
Kenvue (KVUE)
Microsoft Corporation Call Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Adobe Systems Incorporated Call Option (ADBE)
Alphabet Cap Stk Cl C Call Option (GOOG)
Bridgebio Pharma (BBIO)
NVIDIA Corporation Call Option (NVDA)
Bank of America Corporation (BAC)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Intel Corporation Call Option (INTC)

View all positions for Laurion Capital Management

Top funds holding Madrigal Pharmaceuticals

Henderson Group
Baker Bros. Advisors
venBio Select Advisor
Vanguard Group
Paulson & Co
T. Rowe Price Associates
Alliancebernstein
Artisan Partners Limited Partnership
Jane Street
AlpInvest Partners B.V.
RA Capital Management
Perceptive Advisors
Norges Bank Investment Management
Bank of America Corporation
Citadel Advisors

View all funds holding Madrigal Pharmaceuticals